Immatics N.V. Warrants
IMTXW
IMTXW: Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
moreShow IMTXW Financials
Recent trades of IMTXW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by IMTXW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on IMTXW's company Twitter account
Number of mentions of IMTXW in WallStreetBets Daily Discussion
Recent insights relating to IMTXW
Recent picks made for IMTXW stock on CNBC
ETFs with the largest estimated holdings in IMTXW
Flights by private jets registered to IMTXW